DIABETIC CARDIOMYOPATHY. RESISTIN: A CONTROL OF A MYOCARDIAL HYPERTROPHY
Aim. To evaluate the association of serum resistin with morphological and functional indices of hypertrophic myocardium in patients with type 2 diabetes and chronic heart failure (CHF) with preserved left ventricular ejection fraction.Material and methods. Patients (n=60; 12 men and 48 women) with t...
| Published in: | Рациональная фармакотерапия в кардиологии |
|---|---|
| Main Authors: | An. A. Aleksandrov, O. A. Shatskaya, S. S. Kuharenko, M. N. Yadrihinskaya, E. N. Abdalkina, E. N. Drozdova, M. V. Shestakova |
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2015-09-01
|
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/214 |
Similar Items
DIABETIC CARDIOMYOPATHY. RESISTIN: A CONTROL OF A MYOCARDIAL HYPERTROPHY
by: An. A. Aleksandrov, et al.
Published: (2015-09-01)
by: An. A. Aleksandrov, et al.
Published: (2015-09-01)
Electro‐ and echocardiographic features of left ventricle hypertrophy in patients with hypertrophic cardiomyopathy
by: Karolina Bula, et al.
Published: (2022-09-01)
by: Karolina Bula, et al.
Published: (2022-09-01)
Echocardiographic Evaluation of Left Ventricular Hypertrophy
by: Rajesh K. Shah
Published: (2024-08-01)
by: Rajesh K. Shah
Published: (2024-08-01)
Algorithm for Investigation of Fabry Disease in Cardiomyopathies
by: Sandra Marques e Silva, et al.
Published: (2024-10-01)
by: Sandra Marques e Silva, et al.
Published: (2024-10-01)
Myocardial Strain and Association With Clinical Outcomes in Danon Disease: A Model for Monitoring Progression of Genetic Cardiomyopathies
by: Quan M. Bui, et al.
Published: (2021-12-01)
by: Quan M. Bui, et al.
Published: (2021-12-01)
ASSOCIATIONS BETWEEN CLINICAL COURSE, LEFT VENTRICULAR HYPERTROPHY SEVERITY AND ACE GENE I/D POLYMORPHISM IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY AND HYPERTENSIVE HEART
by: M. D. Smirnova, et al.
Published: (2009-04-01)
by: M. D. Smirnova, et al.
Published: (2009-04-01)
An analysis of electrocardiographic criteria for determining left ventricular hypertrophy
by: Carlos Alberto Gasperin, et al.
Published: (2002-01-01)
by: Carlos Alberto Gasperin, et al.
Published: (2002-01-01)
Transplantation of cardiac allografts with left ventricular hypertrophy 1.5 cm and more
by: V. N. Poptsov, et al.
Published: (2019-05-01)
by: V. N. Poptsov, et al.
Published: (2019-05-01)
A rare case of apical hypertrophic cardiomyopathy (AHCM)
by: Seyed Abbas Mirabbasi, et al.
Published: (2017-04-01)
by: Seyed Abbas Mirabbasi, et al.
Published: (2017-04-01)
PERIOPERATIVE PERIOD FOLLOWING HEART TRANSPLANTATION WITH SEVERE LEFT VENTRICULAR HYPERTROPHY
by: V. N. Poptsov, et al.
Published: (2012-05-01)
by: V. N. Poptsov, et al.
Published: (2012-05-01)
Left ventricular hypertrophy: differential diagnosis
by: N.M. Nosenko, et al.
Published: (2020-03-01)
by: N.M. Nosenko, et al.
Published: (2020-03-01)
The role of dietary fatty acids in predicting myocardial structure in fat-fed rats
by: Miller Melissa L, et al.
Published: (2011-06-01)
by: Miller Melissa L, et al.
Published: (2011-06-01)
Comprehensive plasma metabolomics profiling develops diagnostic biomarkers of obstructive hypertrophic cardiomyopathy
by: Hao Cui, et al.
Published: (2025-04-01)
by: Hao Cui, et al.
Published: (2025-04-01)
Hypertrophic Cardiomyopathy and Chronic Kidney Disease: An Updated Review
by: Sheefah Dhuny, et al.
Published: (2024-01-01)
by: Sheefah Dhuny, et al.
Published: (2024-01-01)
LEFT VENTRICULAR HYPERTROPHY IN PATIENTS ON CHRONIC HAEMODIALYSIS
by: A. G. Strokov, et al.
Published: (2010-06-01)
by: A. G. Strokov, et al.
Published: (2010-06-01)
Seamens’ Sign: a novel electrocardiogram prediction tool for left ventricular hypertrophy
by: Philip Walker, et al.
Published: (2022-05-01)
by: Philip Walker, et al.
Published: (2022-05-01)
Identification of candidate cardiomyopathy modifier genes through genome sequencing and RNA profiling
by: Malene E. Lindholm, et al.
Published: (2025-07-01)
by: Malene E. Lindholm, et al.
Published: (2025-07-01)
Left ventricular apical hypertrophy in a transplanted heart: a case report
by: Uzochukwu Ibe, et al.
Published: (2019-04-01)
by: Uzochukwu Ibe, et al.
Published: (2019-04-01)
In search of heart barometer—advantage of left atrial dimension over electrocardiographic indices of left ventricular hypertrophy in arterial hypertension
by: Bogusława Nowak, et al.
Published: (2023-07-01)
by: Bogusława Nowak, et al.
Published: (2023-07-01)
Clinical manifestation and outcomes of children with hypertrophic cardiomyopathy in Kosovo
by: Ramush A Bejiqi, et al.
Published: (2020-04-01)
by: Ramush A Bejiqi, et al.
Published: (2020-04-01)
The detection of left ventricular hypertrophy and diastolic dysfunction
by: G.R. Norton
Published: (2012-04-01)
by: G.R. Norton
Published: (2012-04-01)
Role of Septal Myectomy in Pediatric Hypertrophic Cardiomyopathy
by: Sameh M. Said
Published: (2024-09-01)
by: Sameh M. Said
Published: (2024-09-01)
THE PREVALENCE OF ARTERIAL HYPERTENSION AND THE SPECIFIC FEATURES OF DEVELOPMENT OF LEFT VENTRICULAR HYPERTROPHY IN RADIATION-EXPOSED PERSONS
by: S. K. Kukushkin, et al.
Published: (2015-10-01)
by: S. K. Kukushkin, et al.
Published: (2015-10-01)
Unraveling an Unusual Phenocopy of Hypertrophic Cardiomyopathy: MELAS Syndrome
by: Anna B. Reid, et al.
Published: (2021-02-01)
by: Anna B. Reid, et al.
Published: (2021-02-01)
Prevalence of papillary muscle hypertrophy in fabry disease
by: Tomás Francisco Cianciulli, et al.
Published: (2023-08-01)
by: Tomás Francisco Cianciulli, et al.
Published: (2023-08-01)
Prevalence of myocarditis and its contribution to the course of primary myocardial hypertrophy
by: Yu. A. Lutokhina, et al.
Published: (2023-11-01)
by: Yu. A. Lutokhina, et al.
Published: (2023-11-01)
The modern view on diabetic cardiomyopathy
by: P. Kh. Dzhanashiya, et al.
Published: (2010-04-01)
by: P. Kh. Dzhanashiya, et al.
Published: (2010-04-01)
Factors associated with diagnostic discrepancy for left ventricular hypertrophy between electrocardiography and echocardiography
by: Søren Sandager Petersen, et al.
Published: (2017-01-01)
by: Søren Sandager Petersen, et al.
Published: (2017-01-01)
The Role of Left-Atrial Mechanics Assessed by Two-Dimensional Speckle-Tracking Echocardiography to Differentiate Hypertrophic Cardiomyopathy from Hypertensive Left-Ventricular Hypertrophy
by: Nicoleta-Monica Popa-Fotea, et al.
Published: (2021-04-01)
by: Nicoleta-Monica Popa-Fotea, et al.
Published: (2021-04-01)
Hypertensive Left Ventricular Hypertrophy: Pathogenesis, Treatment, and Health Disparities
by: Sherldine Tomlinson
Published: (2025-07-01)
by: Sherldine Tomlinson
Published: (2025-07-01)
Changing the diagnostic paradigm of the ECG diagnosis of left ventricular hypertrophy
by: Ljuba Bacharova
Published: (2023-10-01)
by: Ljuba Bacharova
Published: (2023-10-01)
Left ventricular hypertrophy in hypertension: Is the electrocardiogram enough for risk stratification?
by: Cesare Cuspidi, et al.
Published: (2023-01-01)
by: Cesare Cuspidi, et al.
Published: (2023-01-01)
Left Ventricular Hypertrophy is Associated with Increased Ostial Pulmonary Vein Diameter
by: Radityo Prakoso, et al.
Published: (2013-06-01)
by: Radityo Prakoso, et al.
Published: (2013-06-01)
Experimental myocardial hypertrophy induced by a minimally invasive ascending aorta coarctation
by: Martins A.S., et al.
Published: (2001-01-01)
by: Martins A.S., et al.
Published: (2001-01-01)
Multidisciplinary approach in the differential diagnosis of left ventricular hypertrophy: a case report
by: M. M. Kudryavtseva, et al.
Published: (2024-03-01)
by: M. M. Kudryavtseva, et al.
Published: (2024-03-01)
Comparison of the association of brachial arterial pressure and parameters of central aortic pressure with left ventricular hypertrophy in the general population of Novosibirsk
by: E. E. Tsvetkova, et al.
Published: (2019-02-01)
by: E. E. Tsvetkova, et al.
Published: (2019-02-01)
Comparison of electrocardiographic versus echocardiographic detection of left ventricular mass changes over time and evaluation of new onset left ventricular hypertrophy
by: Michele Bombelli, et al.
Published: (2023-04-01)
by: Michele Bombelli, et al.
Published: (2023-04-01)
Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network)
by: Mai Tone Lønnebakken, et al.
Published: (2017-03-01)
by: Mai Tone Lønnebakken, et al.
Published: (2017-03-01)
Prevalence of transthyretin amyloid cardiomyopathy in pacemaker patients
by: Eirik Aaseth, et al.
Published: (2024-04-01)
by: Eirik Aaseth, et al.
Published: (2024-04-01)
Left ventricular hypertrophy is associated with increased sirtuin level in newly diagnosed hypertensive patients
by: Hakan Duman, et al.
Published: (2019-08-01)
by: Hakan Duman, et al.
Published: (2019-08-01)
Similar Items
-
DIABETIC CARDIOMYOPATHY. RESISTIN: A CONTROL OF A MYOCARDIAL HYPERTROPHY
by: An. A. Aleksandrov, et al.
Published: (2015-09-01) -
Electro‐ and echocardiographic features of left ventricle hypertrophy in patients with hypertrophic cardiomyopathy
by: Karolina Bula, et al.
Published: (2022-09-01) -
Echocardiographic Evaluation of Left Ventricular Hypertrophy
by: Rajesh K. Shah
Published: (2024-08-01) -
Algorithm for Investigation of Fabry Disease in Cardiomyopathies
by: Sandra Marques e Silva, et al.
Published: (2024-10-01) -
Myocardial Strain and Association With Clinical Outcomes in Danon Disease: A Model for Monitoring Progression of Genetic Cardiomyopathies
by: Quan M. Bui, et al.
Published: (2021-12-01)
